Tazemetostat: a treatment option for relapsed/refractory follicular lymphoma

Mondello, P; Ansell, SM

Ansell, SM (通讯作者),Mayo Clin, Div Hematol & Internal Med, Med, Rochester, MN 55905 USA.

EXPERT OPINION ON PHARMACOTHERAPY, 2022; 23 (3): 295

Abstract

Introduction Follicular lymphoma (FL) is the second most common form of B cell lymphoma and generally presents as an indolent and relatively slow-grow......

Full Text Link